173 related articles for article (PubMed ID: 31525367)
1. A versatile flow-based assay for immunocyte-mediated cytotoxicity.
Rabinovich PM; Zhang J; Kerr SR; Cheng BH; Komarovskaya M; Bersenev A; Hurwitz ME; Krause DS; Weissman SM; Katz SG
J Immunol Methods; 2019 Nov; 474():112668. PubMed ID: 31525367
[TBL] [Abstract][Full Text] [Related]
2. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
[TBL] [Abstract][Full Text] [Related]
3. Optimized cytotoxicity assay for co-suspended effector and target cells.
Cui L; Yin F; Cheng J; Liu H; Zheng M; Liu D; Wu Z; Qian Q
J Immunol Methods; 2021 Oct; 497():113100. PubMed ID: 34270976
[TBL] [Abstract][Full Text] [Related]
4. Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCC.
Hayakawa K; Salmeron MA; Parkinson DR; Markowitz AB; von Eschenbach AC; Legha SS; Balch CM; Ross MI; Augustus LB; Itoh K
J Immunother (1991); 1991 Oct; 10(5):313-25. PubMed ID: 1790139
[TBL] [Abstract][Full Text] [Related]
5. Characterization of CAR T cell expansion and cytotoxic potential during Ex Vivo manufacturing using image-based cytometry.
Maldini CR; Love AC; Tosh KW; Chan LL; Gayout K; Smith T; Riley JL
J Immunol Methods; 2020; 484-485():112830. PubMed ID: 32745474
[TBL] [Abstract][Full Text] [Related]
6. An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells.
Jang YY; Cho D; Kim SK; Shin DJ; Park MH; Lee JJ; Shin MG; Shin JH; Suh SP; Ryang DW
Ann Clin Lab Sci; 2012; 42(1):42-9. PubMed ID: 22371909
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating CD3- NK cells are more effective than CD3+ T cells in killing autologous melanoma cells.
Azogui O; Avril MF; Margulis A; Guillard M; Caillou B; Prade M
J Invest Dermatol; 1991 Sep; 97(3):425-9. PubMed ID: 1831465
[TBL] [Abstract][Full Text] [Related]
8. Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species.
Piriou L; Chilmonczyk S; Genetet N; Albina E
Cytometry; 2000 Dec; 41(4):289-97. PubMed ID: 11084614
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells.
Shiozawa M; Chang CH; Huang YC; Chen YC; Chi MS; Hao HC; Chang YC; Takeda S; Chi KH; Wang YS
BMC Immunol; 2018 Aug; 19(1):27. PubMed ID: 30075754
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment.
Grote S; Ureña-Bailén G; Chan KC; Baden C; Mezger M; Handgretinger R; Schleicher S
Cells; 2021 Apr; 10(5):. PubMed ID: 33925968
[TBL] [Abstract][Full Text] [Related]
11. A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity.
Kandarian F; Sunga GM; Arango-Saenz D; Rossetti M
J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829424
[TBL] [Abstract][Full Text] [Related]
12. Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.
Ueda T; Kumagai A; Iriguchi S; Yasui Y; Miyasaka T; Nakagoshi K; Nakane K; Saito K; Takahashi M; Sasaki A; Yoshida S; Takasu N; Seno H; Uemura Y; Tamada K; Nakatsura T; Kaneko S
Cancer Sci; 2020 May; 111(5):1478-1490. PubMed ID: 32133731
[TBL] [Abstract][Full Text] [Related]
13. Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress.
Renken S; Nakajima T; Magalhaes I; Mattsson J; Lundqvist A; Arnér ESJ; Kiessling R; Wickström SL
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35738800
[TBL] [Abstract][Full Text] [Related]
14. Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay.
Wahlberg BJ; Burholt DR; Kornblith P; Richards TJ; Bruffsky A; Herberman RB; Vujanovic NL
J Immunol Methods; 2001 Jul; 253(1-2):69-81. PubMed ID: 11384670
[TBL] [Abstract][Full Text] [Related]
15. A TCR-based Chimeric Antigen Receptor.
Walseng E; Köksal H; Sektioglu IM; Fåne A; Skorstad G; Kvalheim G; Gaudernack G; Inderberg EM; Wälchli S
Sci Rep; 2017 Sep; 7(1):10713. PubMed ID: 28878363
[TBL] [Abstract][Full Text] [Related]
16. High-Throughput Flow Cytometric Method for the Simultaneous Measurement of CAR-T Cell Characterization and Cytotoxicity against Solid Tumor Cell Lines.
Martinez EM; Klebanoff SD; Secrest S; Romain G; Haile ST; Emtage PCR; Gilbert AE
SLAS Discov; 2018 Aug; 23(7):603-612. PubMed ID: 29634393
[TBL] [Abstract][Full Text] [Related]
17. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
[TBL] [Abstract][Full Text] [Related]
18. Generation of CAR-T Cells for Cancer Immunotherapy.
Xu Q; Harto H; Berahovich R; Xu S; Zhou H; Golubovskaya V; Wu L
Methods Mol Biol; 2019; 1884():349-360. PubMed ID: 30465215
[TBL] [Abstract][Full Text] [Related]
19. An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells.
Peper JK; Schuster H; Löffler MW; Schmid-Horch B; Rammensee HG; Stevanović S
J Immunol Methods; 2014 Mar; 405():192-8. PubMed ID: 24486140
[TBL] [Abstract][Full Text] [Related]
20. A versatile flow cytometry-based assay for the determination of short- and long-term natural killer cell activity.
Johann S; Blümel G; Lipp M; Förster R
J Immunol Methods; 1995 Sep; 185(2):209-16. PubMed ID: 7561131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
